PHVS
PHARVARIS NV
About PHVS
Pharvaris BV is a Switzerland-based clinical-stage company. The activity of the Company focuses on producing oral bradykinin B2-receptor antagonists and is advancing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE).
Buy US stocks in Australia starting with PHVS. Open an account and start investing today!
Market Capitalisation
$319.43M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
38.18K
High today
$9.58
Low today
$8.88
Open price
$9.36
52-week high
$27.50
52-week low
$1.77
PHVS FAQs
How much is one share of PHARVARIS NV?
One share of PHARVARIS NV is valued at $9.57.
What is the ticker symbol for PHARVARIS NV?
The ticker symbol for PHARVARIS NV is PHVS.
How do I buy PHVS shares in Australia?
To buy PHVS stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in PHVS
What is the market capitalisation of PHARVARIS NV PHVS?
As of 30/01/2023 PHARVARIS NV has a market cap of $319M.
What is the 52-week high for PHARVARIS NV stock?
The PHARVARIS NV 52-week high stock price is $27.50.
What is the 52-week low for PHARVARIS NV stock?
The PHARVARIS NV 52-week low stock price is $1.77.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.